Pear secures $50m funding to advance prescription digital therapeutics platform

This article was originally published here

Digital health firm Pear Therapeutics has completed a $50m Series B financing led by Singapore-headquartered investment firm Temasek.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply